EP
Eversept Partners’s Seres Therapeutics MCRB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-418,208
| Closed | -$303K | – | 72 |
|
|
2024
Q2 | $303K | Sell |
418,208
-970,736
| -70% | -$703K | 0.02% | 72 |
|
|
2024
Q1 | $1.08M | Sell |
1,388,944
-364,594
| -21% | -$282K | 0.07% | 65 |
|
|
2023
Q4 | $2.45M | Sell |
1,753,538
-599,018
| -25% | -$839K | 0.22% | 46 |
|
|
2023
Q3 | $5.6M | Sell |
2,352,556
-724,200
| -24% | -$1.72M | 0.47% | 32 |
|
|
2023
Q2 | $14.7M | Buy |
3,076,756
+540,091
| +21% | +$2.59M | 1.23% | 19 |
|
|
2023
Q1 | $14.4M | Buy |
2,536,665
+335,666
| +15% | +$1.9M | 1% | 19 |
|
|
2022
Q4 | $12.3M | Buy |
2,200,999
+265,174
| +14% | +$1.48M | 1.08% | 21 |
|
|
2022
Q3 | $12.4M | Buy |
+1,935,825
| New | +$12.4M | 1.08% | 20 |
|
|
2021
Q3 | – | Sell |
-59,560
| Closed | -$1.42M | – | 100 |
|
|
2021
Q2 | $1.42M | Sell |
59,560
-155,716
| -72% | -$3.71M | 0.09% | 57 |
|
|
2021
Q1 | $4.43M | Sell |
215,276
-118,773
| -36% | -$2.45M | 0.33% | 46 |
|
|
2020
Q4 | $8.18M | Buy |
+334,049
| New | +$8.18M | 0.96% | 29 |
|